Motley Fool Staff

Investors need to look at more than the stock pages.

Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.

We also talk with Whole Foods co-founder John Mackey about his new book, "The Whole Story: Adventures in Love, Life, and Capitalism."

We also put an investor's eye on the cooldown in travel and Walmart's earnings.

Not your thing? Then check out our tips on how to evaluate exchange-traded funds.

We've also got a look at advertising company PubMatic.

We also dig into companies that have more than one CEO.

Let's celebrate!

We chat with Martin Gonzalez, creator of Google's Effective Founders Project.

Two Motley Fool podcasters talk about their experiences.

Relatively strong earnings results from Shopify and Roblox were overshadowed by questions about the outlook for the rest of the year and whether consumers will keep up the online shopping and in-game spending.

When Warren Buffett talks, investors listen. We unpack the quotes and commentary from the market's most anticipated annual meeting and check in on the state of Berkshire Hathaway.

We also check out the 60/40 portfolio, and if it still holds up in 2024.

We've also got a look at Toast's earnings report and how AI is pressuring Chegg.

We've also got a look at what's cooking in the legal marijuana industry.

Motley Fool co-founder David Gardner helps listeners improve at investing, business, and life.

The number of data compromises last year increased by 78% from 2022.

We also talk with Invitation Homes CEO Dallas Tanner about the state of housing.

We also talk about big oil and chat with Tom Chivers, author of "Everything Is Predictable: How Bayesian Statistics Explain Our World."

And we talk with food and beverage analyst David Henkes about Mickey D's CosMc's.